Conjunctivitis, Allergic clinical trials
The registry lists 226 studies for Conjunctivitis, Allergic across more than 10 countries. 19 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-04.
Status
- Completed
- 173
- Status unknown
- 17
- Recruiting
- 11
- Terminated
- 7
- Not yet recruiting
- 7
- Withdrawn
- 6
Phase
- Phase 3
- 69
- Phase 2
- 61
- Phase 4
- 45
- Phase 1
- 18
Where
- United States
- 88
- Germany
- 17
- Canada
- 15
- Italy
- 13
- Spain
- 12
- Japan
- 11
Who runs them
Alcon Research (20) · Bausch & Lomb Incorporated (15) · Allergan (9) · ORA, Inc. (9) · Vistakon Pharmaceuticals (8) · Aldeyra Therapeutics, Inc. (7) · Aciex Therapeutics, Inc. (6) · Faes Farma, S.A. (5)
Studies
Recruiting first, then most recently updated. Showing 50 of 226 — search for more.
- Daydrop® Triple Action for Allergic Eye SymptomsRecruitingNCT07805759Not applicable1 country
- Investigating Nasal and Ocular Immune Response to Conjunctival Allergen ExposureNot yet recruitingNCT078016251 country
- A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat AllergyRecruitingNCT07675811Phase 31 country
- Treatment of Ocular Surface InflammationsRecruitingNCT077328551 country
- A Study to Identify and Characterize Adults and Pediatric Participants With Cat and/or Birch AllergyNot yet recruitingNCT07710846
- An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCEDRecruitingNCT07519902Phase 314 countries
- 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal KeratoconjunctivitisRecruitingNCT06903884Phase 31 country
- Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular SurfaceRecruitingNCT041987401 country
- A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal KeratoconjunctivitisRecruitingNCT07169695Phase 21 country
- Evaluation of TL-925 for the Treatment of Seasonal Allergic ConjunctivitisRecruitingNCT07220408Phase 21 country
- Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization TherapyNot yet recruitingNCT071713071 country
- Tacrolimus Eye Drops in Treatment of Vernal KeratoconjunctivitisNot yet recruitingNCT07138742Not applicable
- Factors Determining Tolerance to Nasal Allergen Exposure With Advanced Age in a Subset of Birch Pollen Allergic SubjectsNot yet recruitingNCT064592191 country
- Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure Chamber-a Randomized Placebo-controlled Double-blind StudyRecruitingNCT06778213Phase 41 country
- Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal KeratoconjunctivitisNot yet recruitingNCT06793514Phase 1
- Corneal Topography in Vernal KeratoconjunctivitisNot yet recruitingNCT067464671 country
- Evaluation of TL-925 for the Treatment of Allergic ConjunctivitisRecruitingNCT06686472Phase 21 country
- The Role of Vitamin D in Corneal Epithelial Barrier Function, Ocular Microbiome, Ocular Inflammation, and Visual Acuity of Children With Allergic ConjunctivitisEnrolling by invitationNCT05839938Not applicable1 country
- A Study of TL-925 for the Treatment of Allergic ConjunctivitisRecruitingNCT06153342Phase 21 country
- Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen AllergyTerminatedNCT07309432Phase 31 country
- The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic ConjunctivitisCompletedNCT05234554Phase 31 country
- A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat AllergyCompletedNCT06602726Phase 32 countries
- A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen AllergyCompletedNCT06602739Phase 32 countries
- OJO-miR: microRNA Expression in Allergic Conjunctivitis.Active, not recruitingNCT073854951 country
- Tyrosine Allergoid Paediatric and Adult StudyActive, not recruitingNCT051860251 country
- The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to PlaceboCompletedNCT01471184Not applicable1 country
- Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular AllergiesCompletedNCT04622345Phase 21 country
- Clinical and Biological Evaluation of NAAGA Versus Azelastine Eye Drops in Allergic Subjects With Tear Film DysfunctionCompletedNCT06800274Phase 41 country
- Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic SolutionCompletedNCT05815758Phase 31 country
- Topical rVA576 for Treatment of Atopic KeratoconjunctivitisTerminatedNCT04037891Phase 1/22 countries
- A Methodology Development Environmental Clinical Trial of Reproxalap in Subjects With Seasonal Allergic ConjunctivitisCompletedNCT03660878Phase 1/21 country
- Evaluation of Central Corneal Thickness in Patients With Vernal Keratoconjunctivitis Using Topical SteroidsActive, not recruitingNCT069137901 country
- A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure ChamberCompletedNCT03709121Phase 1/21 country
- Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedNCT05579730Phase 31 country
- ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic ConjunctivitisCompletedNCT03494504Phase 31 country
- The INVIGORATE Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis.CompletedNCT04207736Phase 31 country
- A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)CompletedNCT00311844Phase 4
- A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy AdultsCompletedNCT05969236Phase 11 country
- A Study Of TL-925 For The Treatment of ACCompletedNCT06293820Phase 21 country
- Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic ManifestationsCompletedNCT038619101 country
- Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.CompletedNCT00769886Phase 31 country
- A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis PatientsCompletedNCT06212973Phase 31 country
- A Safety and Activity Study of NS2 in Subjects With Allergic ConjunctivitisCompletedNCT02578914Phase 21 country
- Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in ChildrenCompletedNCT060630441 country
- Airway Immune Response to Allergens (Use Lay Language Here)Active, not recruitingNCT04619017Phase 11 country
- Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic ConjunctivitisCompletedNCT00836485Phase 21 country
- A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and VehicleCompletedNCT03489941Phase 31 country
- PMCF Study to Evaluate Performance and Safety of "Xanoftal Next"CompletedNCT05829499Not applicable1 country
- PMCF Study to Evaluate Performance and Safety of "Optrex Double Action Soothing and Lubricating Drops"CompletedNCT05824000Not applicable1 country
- Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic ConjunctivitisCompletedNCT02978183Phase 21 country